paroxetine has been researched along with ADDH in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 6 (50.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Aucott, L; Fitton, CA; Fleming, M; Mackay, DF; McLay, JS; Pell, JP; Steiner, MFC | 1 |
| Buoli, M; Cahn, W; Serati, M | 1 |
| Bekker, EM; Buitelaar, JK; Kenemans, JL; Kooij, JJ; Overtoom, CC; van der Molen, MW; Verbaten, MN | 1 |
| Becker, A; Bock, N; Manzke, T; Roessner, V; Rothenberger, A | 1 |
| Bekkering, GE; Tuinier, S; Verbeeck, W | 1 |
| LeBlanc, SR; Ovanessian, MM; Parikh, SV | 1 |
| Coffey, DB; John, N; Potter, PO | 1 |
| Hechtman, L; Weiss, M | 1 |
| Heerdink, ER; van Dijk, L; Volkers, AC | 1 |
| Clement, HW; Gründer, G; Paulzen, M | 1 |
| Barnhill, LJ; Horrigan, JP | 1 |
| Bruun, RD; Budman, CL | 1 |
3 review(s) available for paroxetine and ADDH
| Article | Year |
|---|---|
In utero exposure to antidepressant medication and neonatal and child outcomes: a systematic review.
Topics: Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Child; Conduct Disorder; Congenital Abnormalities; Depressive Disorder; Female; Gestational Age; Heart Defects, Congenital; Humans; Infant, Newborn; Neurodevelopmental Disorders; Paroxetine; Pregnancy; Pregnancy Complications; Premature Birth; Prenatal Exposure Delayed Effects; Risk Factors | 2020 |
Alternative pharmacological strategies for adult ADHD treatment: a systematic review.
Topics: Adrenergic alpha-Agonists; Adult; Amphetamines; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bupropion; Central Nervous System Stimulants; Desipramine; Dopamine Agents; Droxidopa; Drug Combinations; Duloxetine Hydrochloride; Guanfacine; Histamine Agents; Humans; Lisdexamfetamine Dimesylate; Lithium Compounds; Lobeline; Mecamylamine; Memantine; Modafinil; Morpholines; Nicotinic Agonists; Nicotinic Antagonists; Nomifensine; Paroxetine; Pyridines; Pyridoxine; Pyrrolidonecarboxylic Acid; Quinazolinones; Reboxetine; Venlafaxine Hydrochloride; Wakefulness-Promoting Agents | 2016 |
Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review.
Topics: Adrenergic Uptake Inhibitors; Adult; Age Factors; Antidepressive Agents; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Bupropion; Comorbidity; Desipramine; Evidence-Based Medicine; Humans; Lithium Carbonate; Monoamine Oxidase Inhibitors; Paroxetine; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2009 |
3 trial(s) available for paroxetine and ADDH
| Article | Year |
|---|---|
Methylphenidate restores link between stop-signal sensory impact and successful stopping in adults with attention-deficit/hyperactivity disorder.
Topics: Adult; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cerebral Cortex; Double-Blind Method; Female; Humans; Inhibition, Psychological; Male; Methylphenidate; Paroxetine; Placebos; Reaction Time; Selective Serotonin Reuptake Inhibitors | 2009 |
A randomized double-blind trial of paroxetine and/or dextroamphetamine and problem-focused therapy for attention-deficit/hyperactivity disorder in adults.
Topics: Adult; Age Factors; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Combined Modality Therapy; Dextroamphetamine; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Paroxetine; Placebos; Psychiatric Status Rating Scales; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2006 |
Paroxetine treatment of episodic rages associated with Tourette's disorder.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Child; Comorbidity; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Pilot Projects; Rage; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Tic Disorders; Tourette Syndrome; Treatment Outcome | 1998 |
6 other study(ies) available for paroxetine and ADDH
| Article | Year |
|---|---|
Development of 5-HT transporter density and long-term effects of methylphenidate in an animal model of ADHD.
Topics: Age Factors; Animals; Attention Deficit Disorder with Hyperactivity; Carrier Proteins; Central Nervous System Stimulants; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Methylphenidate; Paroxetine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Drug; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins | 2009 |
Advancing bipolar disorder: key lessons from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Bupropion; Combined Modality Therapy; Comorbidity; Database Management Systems; Humans; Inositol; Lamotrigine; Multicenter Studies as Topic; Paroxetine; Psychotherapy, Brief; Randomized Controlled Trials as Topic; Recurrence; Research Design; Risperidone; Smoking; Substance-Related Disorders; Suicide; Treatment Outcome; Triazines; United States; Vitamin B Complex | 2010 |
Onset of abnormal movements and cardiovascular symptoms after acute change in complex polypharmacy in a child with attention-deficit/hyperactivity disorder and mood symptoms.
Topics: Adrenergic alpha-Agonists; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Asthma; Attention Deficit Disorder with Hyperactivity; Cardiovascular Diseases; Chest Pain; Child; Dyskinesia, Drug-Induced; Family; Female; Guanfacine; Humans; Lithium Chloride; Male; Mood Disorders; Neuropsychological Tests; Obesity; Paroxetine; Piperazines; Polypharmacy; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Agitation; Quinolones; Selective Serotonin Reuptake Inhibitors; Smoking; Social Environment | 2012 |
Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001-2005).
Topics: Adolescent; Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Child; Cyclohexanols; Depressive Disorder; Drug Labeling; Drug Prescriptions; Drug Utilization; Family Practice; Female; Humans; Imipramine; Male; Netherlands; Nocturnal Enuresis; Paroxetine; Practice Patterns, Physicians'; Selective Serotonin Reuptake Inhibitors; Tension-Type Headache; Time Factors; Venlafaxine Hydrochloride | 2007 |
Enhancement of atomoxetine serum levels by co-administration of paroxetine.
Topics: Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Drug Interactions; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Male; Paroxetine; Propylamines | 2008 |
Paroxetine-pimozide drug interaction.
Topics: Albinism; Attention Deficit Disorder with Hyperactivity; Blindness; Child; Drug Synergism; Enuresis; Humans; Male; Mood Disorders; Obsessive-Compulsive Disorder; Paroxetine; Pimozide | 1994 |